CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.
Darrell M WilsonSusan L PietropaoloMaria Acevedo-CaladoShuai HuangDestiny AnyaiweDavid ScheinkerAndrea K SteckMadhuri M VasudevanSiripoom V McKayJennifer L SherrKevan C HeroldJessica L DunneCarla J GreenbaumSandra M LordMichael J HallerDesmond A SchatzMark A AtkinsonPatrick W NelsonMassimo Pietropaolonull nullPublished in: Diabetes care (2023)
CGM could aid in the identification of individuals, including those with a normal OGTT, who are likely to rapidly progress to stage 3 type 1 diabetes.
Keyphrases